509 related articles for article (PubMed ID: 24919857)
41. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
Ataergin S; Ozet A; Solchaga L; Turan M; Beyzadeoglu M; Oysul K; Arpaci F; Komurcu S; Surenkok S; Ozturk M
Med Oncol; 2009; 26(3):276-86. PubMed ID: 18989798
[TBL] [Abstract][Full Text] [Related]
42. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
Nataraj V; Batra A; Rastogi S; Khan SA; Sharma MC; Vishnubhatla S; Bakhshi S
J Surg Oncol; 2015 Nov; 112(6):662-8. PubMed ID: 26381138
[TBL] [Abstract][Full Text] [Related]
43. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
Miser JS; Goldsby RE; Chen Z; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore SG; Rausen AR; Vietti TJ; Grier HE
Pediatr Blood Cancer; 2007 Dec; 49(7):894-900. PubMed ID: 17584910
[TBL] [Abstract][Full Text] [Related]
44. [Ewing's sarcoma in children--current surgical treatment options, evaluation of our patients].
Schovanec J; Mrácek J; Havlas V; Trc T
Acta Chir Orthop Traumatol Cech; 2004; 71(4):220-7. PubMed ID: 15456100
[TBL] [Abstract][Full Text] [Related]
45. Survival after recurrence of Ewing's sarcoma family of tumors.
Barker LM; Pendergrass TW; Sanders JE; Hawkins DS
J Clin Oncol; 2005 Jul; 23(19):4354-62. PubMed ID: 15781881
[TBL] [Abstract][Full Text] [Related]
46. [Results of treatment of primary exclusively pulmonary metastatic Ewing sarcoma. A retrospective analysis of 41 patients].
Paulussen M; Braun-Munzinger G; Burdach S; Deneke S; Dunst J; Fellinger E; Göbel U; Mittler U; Treuner J; Voûte PA
Klin Padiatr; 1993; 205(4):210-6. PubMed ID: 8377445
[TBL] [Abstract][Full Text] [Related]
47. Analysis of prognostic factors of pediatric-type sarcomas in adult patients.
Ahn HK; Uhm JE; Lee J; Lim DH; Seo SW; Sung KS; Lee SJ; Lee DJ; Baek KK; Kim WS; Park JO
Oncology; 2011; 80(1-2):21-8. PubMed ID: 21606660
[TBL] [Abstract][Full Text] [Related]
48. Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.
Yildiz I; Sen F; Ekenel M; Darendeliler E; Bavbek S; Agaoglu F; Ozger H; Eralp L; Bilgic B; Basaran M
In Vivo; 2014; 28(3):403-9. PubMed ID: 24815845
[TBL] [Abstract][Full Text] [Related]
49. Extraskeletal Ewing's sarcoma family of tumours in adults: analysis of 57 patients from a single institution.
El Weshi A; Allam A; Ajarim D; Al Dayel F; Pant R; Bazarbashi S; Memon M
Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):374-81. PubMed ID: 20466282
[TBL] [Abstract][Full Text] [Related]
50. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.
Marina NM; Pappo AS; Parham DM; Cain AM; Rao BN; Poquette CA; Pratt CB; Greenwald C; Meyer WH
J Clin Oncol; 1999 Jan; 17(1):180-90. PubMed ID: 10458232
[TBL] [Abstract][Full Text] [Related]
51. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
52. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol.
Elomaa I; Blomqvist CP; Saeter G; Akerman M; Stenwig E; Wiebe T; Björk O; Alvegård TA
Eur J Cancer; 2000 May; 36(7):875-80. PubMed ID: 10785592
[TBL] [Abstract][Full Text] [Related]
53. Treatment results of the Ewing sarcoma of bone and prognostic factors.
Sari N; Toğral G; Cetindağ MF; Güngör BS; Ilhan IE
Pediatr Blood Cancer; 2010 Jan; 54(1):19-24. PubMed ID: 19760772
[TBL] [Abstract][Full Text] [Related]
54. Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients.
Paulussen M; Ahrens S; Craft AW; Dunst J; Fröhlich B; Jabar S; Rübe C; Winkelmann W; Wissing S; Zoubek A; Jürgens H
J Clin Oncol; 1998 Sep; 16(9):3044-52. PubMed ID: 9738574
[TBL] [Abstract][Full Text] [Related]
55. Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma.
Bacci G; Picci P; Mercuri M; Ferrari S; Longhi A; Cesari M; Rosito P; Mancini AF; Barbieri E; Baldini N
Acta Oncol; 1998; 37(7-8):671-6. PubMed ID: 10050985
[TBL] [Abstract][Full Text] [Related]
56. Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
Parambil BC; Vora T; Sankaran H; Prasad M; Bakshi A; Puri A; Gulia A; Qureshi S; Laskar S; Khanna N; Shah S; Ramadwar M; Kembhavi S; Chinnaswamy G; Banavali S
Pediatr Blood Cancer; 2020 Nov; 67(11):e28604. PubMed ID: 32706522
[TBL] [Abstract][Full Text] [Related]
57. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
58. Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.
Halalsheh H; Kaste SC; Krasin MJ; Sykes A; Sahr N; Spunt SL; Federico SM; Bishop MW
Pediatr Blood Cancer; 2020 Apr; 67(4):e28150. PubMed ID: 31944574
[TBL] [Abstract][Full Text] [Related]
59. Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institution.
Bacci G; Boriani S; Balladelli A; Barbieri E; Longhi A; Alberghini M; Scotlandi K; Forni C; Pollastri P; Vanel D; Mercuri M
Eur Spine J; 2009 Aug; 18(8):1091-5. PubMed ID: 19277725
[TBL] [Abstract][Full Text] [Related]
60. Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report.
Laws HJ; Burdach S; van Kaick B; Engel B; Dirksen U; Körholz D; Pape H; Kahn T; Merck H; Schmitz M; Heyll A; Dockhorn-Dworniczak B; Jürgens H; Göbel U
Strahlenther Onkol; 1999 Oct; 175(10):488-94. PubMed ID: 10554643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
